Compumedics Ltd (CMP) - Total Assets
Based on the latest financial reports, Compumedics Ltd (CMP) holds total assets worth AU$54.39 Million AUD (≈ $38.48 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Compumedics Ltd - Total Assets Trend (2000–2025)
This chart illustrates how Compumedics Ltd's total assets have evolved over time, based on quarterly financial data. Also see Compumedics Ltd market capitalisation for the company's overall valuation and market capitalisation.
Compumedics Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Compumedics Ltd's total assets of AU$54.39 Million consist of 64.8% current assets and 35.3% non-current assets. Review Compumedics Ltd total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 5.0% |
| Accounts Receivable | AU$14.88 Million | 27.4% |
| Inventory | AU$14.66 Million | 27.0% |
| Property, Plant & Equipment | AU$1.78 Million | 3.3% |
| Intangible Assets | AU$16.59 Million | 30.5% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2000–2025)
This chart illustrates how Compumedics Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See current stock price of Compumedics Ltd for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Compumedics Ltd's current assets represent 64.8% of total assets in 2025, a decrease from 66.0% in 2000.
- Cash Position: Cash and equivalents constituted 5.0% of total assets in 2025, down from 38.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, an increase from 21.0% in 2000.
- Asset Diversification: The largest asset category is intangible assets at 30.5% of total assets.
Compumedics Ltd Competitors by Total Assets
Key competitors of Compumedics Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ:LMRI
|
USA | $1.81 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581
|
China | CN¥2.70 Billion |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
Dirui Industrial Co Ltd
SHE:300396
|
China | CN¥2.57 Billion |
|
Hi-Clearance
TWO:1788
|
Taiwan | NT$4.99 Billion |
|
MODULIGHT OY EO 1
F:78W
|
Germany | €46.32 Million |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Compumedics Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.10 | 1.23 | 2.32 |
| Quick Ratio | 0.64 | 0.61 | 1.61 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | AU$3.10 Million | AU$4.99 Million | AU$16.45 Million |
Compumedics Ltd - Advanced Valuation Insights
This section examines the relationship between Compumedics Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.22 |
| Latest Market Cap to Assets Ratio | 0.65 |
| Asset Growth Rate (YoY) | 34.8% |
| Total Assets | AU$54.39 Million |
| Market Capitalization | $35.34 Million USD |
Valuation Analysis
Below Book Valuation: The market values Compumedics Ltd's assets below their book value (0.65x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Compumedics Ltd's assets grew by 34.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Compumedics Ltd (2000–2025)
The table below shows the annual total assets of Compumedics Ltd from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$54.39 Million ≈ $38.48 Million |
+34.77% |
| 2024-06-30 | AU$40.36 Million ≈ $28.56 Million |
-2.00% |
| 2023-06-30 | AU$41.18 Million ≈ $29.14 Million |
-1.26% |
| 2022-06-30 | AU$41.71 Million ≈ $29.51 Million |
+8.21% |
| 2021-06-30 | AU$38.55 Million ≈ $27.27 Million |
+8.50% |
| 2020-06-30 | AU$35.53 Million ≈ $25.14 Million |
-8.11% |
| 2019-06-30 | AU$38.66 Million ≈ $27.36 Million |
+11.57% |
| 2018-06-30 | AU$34.65 Million ≈ $24.52 Million |
+18.56% |
| 2017-06-30 | AU$29.23 Million ≈ $20.68 Million |
+11.89% |
| 2016-06-30 | AU$26.12 Million ≈ $18.48 Million |
+20.52% |
| 2015-06-30 | AU$21.68 Million ≈ $15.34 Million |
+11.03% |
| 2014-06-30 | AU$19.52 Million ≈ $13.81 Million |
+2.28% |
| 2013-06-30 | AU$19.09 Million ≈ $13.51 Million |
-3.96% |
| 2012-06-30 | AU$19.88 Million ≈ $14.06 Million |
-13.98% |
| 2011-06-30 | AU$23.10 Million ≈ $16.35 Million |
+5.93% |
| 2010-06-30 | AU$21.81 Million ≈ $15.43 Million |
+1.65% |
| 2009-06-30 | AU$21.46 Million ≈ $15.18 Million |
+6.53% |
| 2008-06-30 | AU$20.14 Million ≈ $14.25 Million |
+4.63% |
| 2007-06-30 | AU$19.25 Million ≈ $13.62 Million |
-13.19% |
| 2006-06-30 | AU$22.18 Million ≈ $15.69 Million |
-9.67% |
| 2005-06-30 | AU$24.55 Million ≈ $17.37 Million |
+0.16% |
| 2004-06-30 | AU$24.51 Million ≈ $17.34 Million |
+3.14% |
| 2003-06-30 | AU$23.76 Million ≈ $16.81 Million |
-45.53% |
| 2002-06-30 | AU$43.62 Million ≈ $30.87 Million |
+11.29% |
| 2001-06-30 | AU$39.20 Million ≈ $27.73 Million |
+13.75% |
| 2000-06-30 | AU$34.46 Million ≈ $24.38 Million |
-- |
About Compumedics Ltd
Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST… Read more